BREAKING NEWS: Top Woman at FDA Resigns over EC Delay
Susan Wood, PhD, the top woman at the Food and Drug Administration (FDA), announced her resignation today because of the continued FDA delay on over-the-counter status for emergency contraception (EC). In a letter announcing her resignation, Wood, who was the Assistant Commissioner for Women’s Health and Director of the FDA Office of Women’s Health, wrote, “The recent decision announced by the Commissioner about emergency contraception, which continues to limit women's access to a product that would reduce unintended pregnancies and reduce abortions is contrary to my core commitment to improving and advancing women's health.”
“I have spent the last 15 years working to ensure that science informs good health policy decisions. I can no longer serve as staff when scientific and clinical evidence, fully evaluated and recommended for approval by the professional staff here, has been overruled,” Wood wrote.
“I am sad to see such a champion for women’s health leave the FDA, but I understand the frustration she must feel as the FDA is shockingly placing ideology and politics above science and medicine,” said Eleanor Smeal, president of the Feminist Majority Foundation. “The FDA’s stall tactics on EC are only harming women and increasing the need for abortions.”
5/6/2015 Four Sentenced to Death, Eight to Prison for Brutal Murder of Afghan Woman - The verdict for the 49 men charged with the murder of 27-year- old Farkhunda came yesterday, following a highly publicized and televised week-long trial and public outrage for violence against women in Afghanistan.
Farkhunda, who was an Islamic law student, accused a local Mullah of acting inappropriately. . . .
5/5/2015 Sen. Reid Promises to Filibuster "Fast Track" for the TransPacific Partnership - Senate Democratic Leader Harry Reid has promised to delay efforts to push through the controversial Trans-Pacific Partnership trade deal until the Senate first deals with two stalled bills that may soon expire.
Reid says that the two measures, an infrastructure bill on highway funding, and reforms to the Foreign Intelligence Surveillance Act (FISA), are "very complicated issues," that require the Senate's attention "before we even deal with [the Trans-Pacific Partnership]."
The Trans-Pacific Partnership (TPP), a massive free trade agreement currently being promoted by the Obama Administration, has been heavily criticized by humanitarian groups, environmental groups, and medical groups. . . .